Melanoma Prevalence, Mortality Mostly Stable Over the Past 30 Years
Data from this new study suggest melanoma cases rose at a slower rate in lower-income countries, but the authors say that may be due to differences in case documentation.
Data from this new study suggest melanoma cases rose at a slower rate in lower-income countries, but the authors say that may be due to differences in case documentation.
Posted in Melanoma News, Health Professionals, Of Interest
Many melanoma patients presented with more advanced disease during the COVID-19 pandemic, according to a small study published in the Journal of the American Academy of Dermatology.
Posted in Melanoma News, Health Professionals, Of Interest
The combination of sotigalimab (APX005M) and nivolumab (Opdivo) elicited durable responses with a reasonable safety profile in patients with melanoma who were refractory to anti–PD-1 therapy, according to data from a phase 2 trial (NCT03123783).
Posted in Melanoma News, Health Professionals, Clinical Trials
Immunotherapy, intralesional treatments, multidisciplinary care teams define rapidly-evolving multimodal approach.
Posted in Melanoma News, Health Professionals, Of Interest